Ejso最新文献

筛选
英文 中文
Long-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer. 优化急性右侧梗阻性结肠癌患者延迟手术后的长期预后。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-06 DOI: 10.1016/j.ejso.2024.109521
Elize W Lockhorst, Jeske R E Boeding, Lissa Wullaert, Robert R J Coebergh van den Braak, Arjen M Rijken, Cornelis Verhoef, Paul D Gobardhan, Jennifer M J Schreinemakers
{"title":"Long-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer.","authors":"Elize W Lockhorst, Jeske R E Boeding, Lissa Wullaert, Robert R J Coebergh van den Braak, Arjen M Rijken, Cornelis Verhoef, Paul D Gobardhan, Jennifer M J Schreinemakers","doi":"10.1016/j.ejso.2024.109521","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109521","url":null,"abstract":"<p><strong>Aim: </strong>To retrospectively analyse the short- and long-term oncological, morbidity and mortality outcomes in patients diagnosed with acute right-sided obstructing colon cancer. Patients who underwent pre-optimisation prior to the oncological resection were compared to patients who did not undergo pre-optimisation.</p><p><strong>Methods: </strong>All consecutive patients with right-sided obstructing colon cancer, either with a high clinical suspicion or confirmed diagnosis by histological analysis, who underwent curative-intent treatment between March 2013 and December 2020 were included. Patients were divided into two groups: an optimised group and a non-optimised group. Preoperative optimisation included additional nutrition, physiotherapy, and, if needed, bowel decompression. Data about disease-free survival and mortality were collected up to three years after surgery.</p><p><strong>Results: </strong>Sixty-two patients were included. Thirty patients underwent the optimisation protocol before postponed surgery, and 32 patients received emergency surgery, without optimisation (surgery performed with a median of 9.6 days versus 22 h after admission). The postoperative complication rate was significantly lower in the optimisation group (50 % vs 78 %, p = 0.033). No significant differences were found in the 90-day mortality rate (7 % vs 13 %, p = 0.672) and three-year overall survival rate (43 % vs 56 %, p = 0.49). After three years, sixteen (53 %) patients in the optimised group and twenty (63 %) in the non-optimised were deceased (p = 0.672).</p><p><strong>Conclusion: </strong>Postponing the surgery with preoperative optimisation in patients with obstructing right-sided colon cancer results in a significantly lower 90-day complication rate and suggests no negative effect on survival rates compared to an acute resection. Although, further research with a larger sample size is needed.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 2","pages":"109521"},"PeriodicalIF":3.5,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomes. 是时候重新考虑人工合成补片在乳房再造中的应用了:它们的使用对短期结果的影响。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-06 DOI: 10.1016/j.ejso.2024.108780
Eléa Leroy, Laura Poirier, Hélène Planque, Jean-François Le Brun, Léopold Gaichies, Sandrine Martin Françoise, Roman Rouzier, Valentin Harter, Enora Dolivet
{"title":"Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomes.","authors":"Eléa Leroy, Laura Poirier, Hélène Planque, Jean-François Le Brun, Léopold Gaichies, Sandrine Martin Françoise, Roman Rouzier, Valentin Harter, Enora Dolivet","doi":"10.1016/j.ejso.2024.108780","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108780","url":null,"abstract":"<p><strong>Background: </strong>Breast reconstruction practices, predominantly implant-based, have evolved, with meshes aiding in overcoming traditional limitations. However, data comparing mesh-assisted prepectoral reconstruction with implants alone are lacking. This study aimed to assess whether synthetic meshes in prepectoral reconstruction impact postoperative complications.</p><p><strong>Material and methods: </strong>We retrospectively studied 238 prepectoral immediate implant-based breast reconstructions (IBBR) in 211 patients from 2020 to 2022. Our primary endpoint was the 90-day revision surgery rate comparing mesh and non-mesh groups. Secondary endpoints included postoperative complications: seroma formation, skin necrosis, implant exposure, hematomas, surgical site infections, and implant loss. We conducted univariate and multivariate analyses to assess complications and risk factors for postoperative revision in the entire cohort.</p><p><strong>Results: </strong>There was a statistically significant higher rate of revision surgery in the mesh group (22 % vs. 9.0 %, p = 0.022) and more early complications in the mesh group, although there was no significant difference between the two groups. During the study period, the number of immediate IBBR significantly increased, reflecting expanded surgical indications that were no longer dependent on potential adjuvant treatments. and practices have changed. The multivariate analysis revealed no specific evidence of mesh use affecting surgical revision. However, it identified implant volume as a significant factor increasing the risk of revision surgery (p = 0.01).</p><p><strong>Conclusion: </strong>This study underscores a significant practice shift: standardizing surgical techniques, particularly reducing mesh usage, did not lead to higher revision surgery rates. These findings suggest that the non-mesh assisted prepectoral approach is a valid technique.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 3","pages":"108780"},"PeriodicalIF":3.5,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142913991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis". 对“局部晚期直肠癌根治性切除吻合术后保护性造口逆转后渗漏的相关因素”的评论。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-06 DOI: 10.1016/j.ejso.2024.109508
Youchang Sun, Sheng Li
{"title":"Comment on \"Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis\".","authors":"Youchang Sun, Sheng Li","doi":"10.1016/j.ejso.2024.109508","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109508","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"109508"},"PeriodicalIF":3.5,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery. 用于增强消化道肿瘤和肝转移手术引导的荧光纳米抗体。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-06 DOI: 10.1016/j.ejso.2024.109537
Łukasz Mateusiak, Sarah Hakuno, Eveline S M de Jonge-Muller, Sam Floru, Cornelis F M Sier, Lukas J A C Hawinkels, Sophie Hernot
{"title":"Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery.","authors":"Łukasz Mateusiak, Sarah Hakuno, Eveline S M de Jonge-Muller, Sam Floru, Cornelis F M Sier, Lukas J A C Hawinkels, Sophie Hernot","doi":"10.1016/j.ejso.2024.109537","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109537","url":null,"abstract":"<p><strong>Background: </strong>Fluorescence molecular imaging, a potent and non-invasive technique, has become indispensable in medicine for visualizing molecular processes. In surgical oncology, it aids treatment by allowing visualization of tumor cells during fluorescence-guided surgery (FGS). Targeting the urokinase plasminogen activator receptor (uPAR), overexpressed during tissue remodeling and inflammation, holds promise for advancing FGS by specifically highlighting tumors. This study explores the extended use of Nanobody-based (Nb) anti-uPAR tracers, evaluating their receptor binding, ability to visualize and demarcate colorectal (CRC) and gastric cancer (GC), and detect localized (PC) and metastatic (PC-M) pancreatic carcinoma.</p><p><strong>Methods: </strong>First, the receptor structure interactions of Nb15, which binds specifically to the human homologue of uPAR, were characterized in vitro to deepen our understanding of these interactions. Subsequently, Nbs 15 and 13-where Nb13 targets the murine uPAR homologue-were labeled with the s775z fluorescent dye and validated in a randomized study in mice (n = 4 per group) using orthotopic human CRC, GC, and PC models, as well as a mouse PC-M model.</p><p><strong>Results: </strong>Nb15, which binds to the D1 domain of uPAR and competes with urokinase's binding fragment, showed rapid and specific tumor accumulation. It exhibited higher tumor-to-background ratios in CRC (3.35 ± 0.75) and PC (3.41 ± 0.46), and effectively differentiated tumors in GC (mean fluorescence intensity: 0.084 ± 0.017), as compared to control Nbs. Nb13 successfully identified primary tumors and liver metastases in PC-M models.</p><p><strong>Conclusion: </strong>The tested fluorescently-labeled anti-uPAR Nbs show significant preclinical and clinical potential for improving surgical precision and patient outcomes, with Nb15 demonstrating promise for real-time surgical guidance.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 3","pages":"109537"},"PeriodicalIF":3.5,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142926856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study. 哪个替代终点最能预测局部晚期胃癌患者接受新辅助化疗免疫治疗后手术的生存?一项多中心回顾性研究。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-05 DOI: 10.1016/j.ejso.2024.109517
Xiong Sun, Xuanfei Li, Shijun Zhao, Chengguo Li, Yao Lin, Qian Shen, Jianing Ding, Tianhao Li, Yuping Yin, Kaixiong Tao
{"title":"Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study.","authors":"Xiong Sun, Xuanfei Li, Shijun Zhao, Chengguo Li, Yao Lin, Qian Shen, Jianing Ding, Tianhao Li, Yuping Yin, Kaixiong Tao","doi":"10.1016/j.ejso.2024.109517","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109517","url":null,"abstract":"<p><strong>Introduction: </strong>Recent clinical researches have reported that neoadjuvant chemoimmunotherapy (NCIT) significantly improve the pathological complete response (pCR) and major pathological response (MPR) rates. However, surrogate endpoints for survival remains controversy for locally advanced gastric cancer (LAGC) after NCIT.</p><p><strong>Methods: </strong>A retrospective analysis was performed on 84 patients with LAGC who had undergone NCIT following radical resection in three medical centers in China, between July 2020 and September 2023. Survival curves for event-free survival (EFS) and overall survival (OS) were estimated using the Kaplan-Meier method, and the log-rank test was used to compare survival outcomes. Univariate and multivariate analyses for prognostic factors were based on Cox regression analysis.</p><p><strong>Results: </strong>The rates of ypN0, pCR and MPR were 60.7 % (51/84), 26.2 % (22/84) and 39.3 %(33/84),respectively. Patients with ypN0 had better EFS and OS than those with ypN+ (all p < 0.05). Survival was equivalent between pCR and non-pCR group (all p > 0.05). while patients with MPR had better EFS than those with non-MPR (p = 0.028). Furthermore, a multivariate analysis revealed that the lymph nodes(LNs) status was an independent prognostic factor for the EFS (hazard ratio [HR] 5.533, 95 % confidence interval [CI] 1.186-25.804, p = 0.029) and OS (HR 5.116, 95 % CI 1.357-19.281, p = 0.016), but not pCR and MPR (all p > 0.05). Based on the status of pathologic LNs, ypN0 group showed lower depth of tumor invasion, and lower rate of perineural and vascular invasion (all p < 0.05).</p><p><strong>Conclusion: </strong>These findings demonstrated that ypN0 may be important as a surrogate of favorable clinical outcome in LAGC patients who received NCIT plus curative surgery.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 2","pages":"109517"},"PeriodicalIF":3.5,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of obesity on outcomes following surgery for gastric adenocarcinoma: A European multi-institutional study. 肥胖对胃腺癌手术后预后的影响:一项欧洲多机构研究
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-05 DOI: 10.1016/j.ejso.2024.109518
Ophélie Bacoeur-Ouzillou, Thibault Voron, Céline Lambert, David Fuks, Guillaume Piessen, Gilles Manceau, Jérome Guiramand, Denis Pezet, Caroline Gronnier, Johan Gagnière
{"title":"Impact of obesity on outcomes following surgery for gastric adenocarcinoma: A European multi-institutional study.","authors":"Ophélie Bacoeur-Ouzillou, Thibault Voron, Céline Lambert, David Fuks, Guillaume Piessen, Gilles Manceau, Jérome Guiramand, Denis Pezet, Caroline Gronnier, Johan Gagnière","doi":"10.1016/j.ejso.2024.109518","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109518","url":null,"abstract":"<p><strong>Introduction: </strong>The impact of overweight and obesity on pathological outcomes, complications, and oncologic outcomes following surgery for gastric adenocarcinoma has been poorly reported in Western populations. This study aimed to better understand the impact of overweight and obesity on both surgical and oncological outcomes in patients who underwent surgery for gastric cancer.</p><p><strong>Methods: </strong>Data were retrospectively collected from a multi-institutional European database. 1589 patients underwent surgery for gastric adenocarcinoma between 2007 and 2017. Patients were divided into three groups according to their body mass index (BMI): 722 normoponderal patients (45.4 %), 585 overweight patients (36.8 %), and 282 obese patients (17.7 %).</p><p><strong>Results: </strong>The tumor stage, administration of perioperative chemotherapy, number of harvested lymph nodes, and reoperation rates were similar. Tumor location differed between the groups, with more distal locations in normoponderal patients than in overweight patients (51.4 % vs. 44.1 %, p = 0.04). Surgical complications were more frequent in obese patients than in normoponderal patients (34.8 % vs. 24.2 %, p = 0.005), and severe postoperative complications too. The medical complication rate was higher in overweight and obese patients (31.5 % and 32.6 % vs. 24.1 %, p = 0.003). There was no difference in the overall survival.</p><p><strong>Conclusions: </strong>Obesity was not related to tumor stage, pre- or intraoperative strategies, or survival in patients undergoing surgery for gastric adenocarcinoma. However, postoperative morbidity increases in patients with obesity. Surgery for gastric adenocarcinoma should be proposed for all patients and should be performed as usual, regardless of their BMI. However, obese patients should be counseled regarding the higher risk of postoperative complications.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 2","pages":"109518"},"PeriodicalIF":3.5,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative surgical navigation improves margin status in advanced malignancies of the anterior craniofacial area: A prospective observational study with systematic review of the literature and meta-analysis. 术中手术导航改善颅面前部晚期恶性肿瘤的切缘状态:一项前瞻性观察性研究,系统回顾文献和荟萃分析。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-04 DOI: 10.1016/j.ejso.2024.109514
Marco Ferrari, Piergiorgio Gaudioso, Stefano Taboni, Giacomo Contro, Giuseppe Roccuzzo, Paola Costantino, Michael J Daly, Harley H L Chan, Maxime Fieux, Alessandra Ruaro, Roberto Maroldi, Alberto Signoroni, Alberto Deganello, Jonathan C Irish, Florent Carsuzaa, Piero Nicolai
{"title":"Intraoperative surgical navigation improves margin status in advanced malignancies of the anterior craniofacial area: A prospective observational study with systematic review of the literature and meta-analysis.","authors":"Marco Ferrari, Piergiorgio Gaudioso, Stefano Taboni, Giacomo Contro, Giuseppe Roccuzzo, Paola Costantino, Michael J Daly, Harley H L Chan, Maxime Fieux, Alessandra Ruaro, Roberto Maroldi, Alberto Signoroni, Alberto Deganello, Jonathan C Irish, Florent Carsuzaa, Piero Nicolai","doi":"10.1016/j.ejso.2024.109514","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.109514","url":null,"abstract":"<p><p>The current scientific evidence suggests that surgical navigation (SN) can contribute to improve oncologic outcomes in sinonasal and craniofacial surgery. The present study investigated the feasibility of intraoperative SN and its role in improving the outcomes of surgically treated sinonasal and craniofacial tumors. This prospective study compared navigation-guided surgery for sinonasal or craniofacial malignancies with a pair-matched cohort (1:2 matching) of patients operated without SN. A systematic review of the literature was performed. Thirty-five patients who underwent navigation-guided surgery were included. The pair-matched control cohort included 70 patients operated without SN. The margin status analysis demonstrated a lower rate of positive margins (p = 0.013) in the SN group, especially in pT4 (p = 0.034), recurrent (p = 0.024), high-grade tumors (p = 0.043), and endoscopic-assisted open surgery (p = 0.035). The mean preoperative time did not show a significant difference between surgeries performed with or without SN (1.26 vs. 1.23 h, p = 0.445). However, surgeries utilizing SN had a significantly longer median duration compared to those without (8.10 vs. 6.00 h, p = 0.029). A total of 209 patients were included in the meta-analysis; 91 patients (43.5 %) underwent surgery with SN. The results of the meta-analysis showed an improvement in terms of negative margins rate with the use of SN (OR = 2.62; 95%-confidence interval: 1.33-5.17). In conclusion, intraoperative SN can contribute to achieve a clear margin resection, especially in locally advanced tumors, recurrences, highly aggressive histologies, and when endoscopic-assisted open surgery is employed.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 2","pages":"109514"},"PeriodicalIF":3.5,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Comparison of the LiMAx test vs. the APRI+ALBI score – Incorrect comparison parameters lead to questionable results 答复LiMAx测试与APRI+ALBI评分的比较--不正确的比较参数会导致可疑的结果。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-01 DOI: 10.1016/j.ejso.2024.108696
Jonas Santol, Markus Ammann, Tim Reese, Felix Oldhafer, Yawen Dong, Moritz Schmelzle, Karl J. Oldhafer, Hubert Hackl, Thomas Gruenberger, Patrick Starlinger
{"title":"Reply to: Comparison of the LiMAx test vs. the APRI+ALBI score – Incorrect comparison parameters lead to questionable results","authors":"Jonas Santol,&nbsp;Markus Ammann,&nbsp;Tim Reese,&nbsp;Felix Oldhafer,&nbsp;Yawen Dong,&nbsp;Moritz Schmelzle,&nbsp;Karl J. Oldhafer,&nbsp;Hubert Hackl,&nbsp;Thomas Gruenberger,&nbsp;Patrick Starlinger","doi":"10.1016/j.ejso.2024.108696","DOIUrl":"10.1016/j.ejso.2024.108696","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 108696"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advert 2025 BASO Annual Conference 广告2025 BASO年会
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-01 DOI: 10.1016/j.ejso.2024.109494
{"title":"Advert 2025 BASO Annual Conference","authors":"","doi":"10.1016/j.ejso.2024.109494","DOIUrl":"10.1016/j.ejso.2024.109494","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 109494"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142748714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Vaginal surgery for cervical cancer based on the recent results of LACC, SHAPE, SUCCOR and ConCerv trials 回复:基于 LACC、SHAPE、SUCCOR 和 ConCerv 试验最新结果的宫颈癌阴道手术。
IF 3.5 2区 医学
Ejso Pub Date : 2024-12-01 DOI: 10.1016/j.ejso.2024.108656
Limor Helpman, Laurence Bernard, Gregory Pond
{"title":"Reply to: Vaginal surgery for cervical cancer based on the recent results of LACC, SHAPE, SUCCOR and ConCerv trials","authors":"Limor Helpman,&nbsp;Laurence Bernard,&nbsp;Gregory Pond","doi":"10.1016/j.ejso.2024.108656","DOIUrl":"10.1016/j.ejso.2024.108656","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 108656"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信